You are here
Stryker Orthopaedics is known for the development and manufacture of specialty surgical products and other medical supplies for health care around the world. They have manufactured scores of medical devices and joint replacement products, most of which have been successful; however some of the hip replacement devices have caused serious adverse events resulting in injury to hundreds of patients.
The Stryker Rejuvenate Modular-Neck Stem and the ABG Modular-Neck Stem hip replacement devices were approved by the Food and Drug Administration (FDA) in 2008 and 2009. These devices are not typical "metal-on-metal" (MoM), the device necks are built of Cobalt and Chromium and the neck stems are layered with Titanium. Though the intention was to make it corrosion resistant, at the connection, the two metals rubbed on each other and did release toxic metal ions and debris. Stryker recalled the Rejuvenate Modular and ABG II Modular-Neck Hip Stems in 2012 and stopped all global sales and production of these components. Another hip stems models like the Accolade TMZF also caused problems and were recalled in 2009, 2011 and 2013.
Major complications include:
- Metallosis (the buildup of metal ions in the body)
- Inflammation and swelling
- Limited mobility
- Bone, joint, muscle or neurological damage
- Necrosis-tissue and bone death due to metallosis toxicity
- Popping, crunching or other noises from the hip caused by movement
- Fractures of one or more components
Most patients with Stryker Rejuvenate and ABG II implants have undergone additional surgery or revision surgeries to remove and replace the implant to repair or reconstruct injured joints, bones, and tissue in addition to the replacement surgery.
Lawsuit & Settlement:
Hip recipients who were injured by Stryker's Rejuvenate and ABG II neck and stem implants filed lawsuits against Stryker Orthopaedics. Suit alleges that Stryker designed faulty devices, failed to adequately test them in humans before marketing, failed to warn the public and medical community, and concealed information about the risks of adverse events caused by the devices.
In November 2014, Stryker agreed to settle several thousand claims for $1.4 billion. This settlement encompasses cases in the New Jersey MCL and the Minnesota MDL; and all claimants who had revision surgery before Nov. 3, 2014.
Evidence to be looked for in potential cases
- Indication of Stryker hip usage in Medical Records
- Implant Sticker and relevant details like Product Code, Manufacturer, Lot number
- Follow up complications and their treatment after Stryker hip implant insertion
- Revision surgeries and implants
Medical Record Review and claim validation of Stryker Hip Implant case should take approximately 3 hours in most instances; however, this approximation may vary in cases based on the volume of records.